FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Marie Asemissen

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Anne Marie Asemissen; Aristoteles Giagounidis
If it ain't broke, don't fix it!
Antonia Busse; Anne Marie Asemissen; Anika Nonnenmacher; Floriane Braun; Sebastian Ochsenreither; David Stather; Alberto Fusi; Alexander Schmittel; Kurt Miller; Eckhard Thiel; Ulrich Keilholz
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
Anne Marie Asemissen; Peter Brossart
Vaccination strategies in patients with renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Marie Asemissen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Anne Marie Asemissen; Aristoteles Giagounidis
If it ain't broke, don't fix it!
Haematologica 2011;96(11):e44.
2011: Antonia Busse; Anne Marie Asemissen; Anika Nonnenmacher; Floriane Braun; Sebastian Ochsenreither; David Stather; Alberto Fusi; Alexander Schmittel; Kurt Miller; Eckhard Thiel; Ulrich Keilholz
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2011;47(5):690-6.
2009: Anne Marie Asemissen; Peter Brossart
Vaccination strategies in patients with renal cell carcinoma.
Cancer immunology, immunotherapy : CII 2009;58(7):1169-74.
2009: Ulrich Keilholz; Anne Letsch; Antonia Busse; Anne Marie Asemissen; Sandra Bauer; Igor Wolfgang Blau; Wolf-Karsten Hofmann; Lutz Uharek; Eckhard Thiel; Carmen Scheibenbogen
A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.
Blood 2009;113(26):6541-8.
2009: Anne Marie Asemissen; Doreen Haase; Stefan Stevanovic; Sandra Bauer; Antonia Busse; Eckhard Thiel; Hans-Georg Rammensee; Ulrich Keilholz; Carmen Scheibenbogen
Identification of an immunogenic HLA-A*0201-binding T-cell epitope of the transcription factor PAX2.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(4):370-5.
2009: Kaja Zimmermann; Alexander Schmittel; Ursula Steiner; Anne Marie Asemissen; Maren Knoedler; Eckhard Thiel; Kurt Miller; Ulrich Keilholz
Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.
Oncology 2009;76(5):350-4.
2007: Anne Letsch; Maren Knoedler; Il-Kang Na; Florian Kern; Anne Marie Asemissen; Ulrich Keilholz; Michael Loesch; Eckhard Thiel; Hans-Dieter Volk; Carmen Scheibenbogen
CMV-specific central memory T cells reside in bone marrow.
European journal of immunology 2007;37(11):3063-8.
2007: Il-Kang Na; Ulrich Keilholz; Anne Letsch; Sandra Bauer; Anne Marie Asemissen; Dirk Nagorsen; Eckhard Thiel; Carmen Scheibenbogen
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells.
Cancer immunology, immunotherapy : CII 2007;56(3):391-6.
2006: Anne Marie Asemissen; Ulrich Keilholz; Stefan Tenzer; Margret Müller; Steffen Walter; Stefan Stevanovic; Hansjörg Schild; Anne Letsch; Eckhard Thiel; Hans-Georg Rammensee; Carmen Scheibenbogen
Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7476-82.
2006: Andreas Wadle; Gerhard Held; Frank Neumann; Sascha Kleber; Beate Wuellner; Anne Marie Asemissen; Boris Kubuschok; Carmen Scheibenbogen; Tanja Breinig; Andreas Meyerhans; Christoph Renner
Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae.
Vaccine 2006;24(37-39):6272-81.
2006: Robert Godal; Ulrich Keilholz; Lutz Uharek; Anne Letsch; Anne Marie Asemissen; Antonia Busse; Il-Kang Na; Eckhard Thiel; Carmen Scheibenbogen
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
Blood 2006;107(8):3205-11.
2006: Anne Letsch; Ulrich Keilholz; Florian Kern; Anne Marie Asemissen; Eckhard Thiel; Carmen Scheibenbogen
Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptides.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):201-7.
2006: Alexander Schmittel; Carmen Scheibenbogen; Anne Letsch; Anne Marie Asemissen; Eckhard Thiel; Ulrich Keilholz
Malignant melanoma--clinical development of peptide-based melanoma vaccines.
Frontiers of radiation therapy and oncology 2006;39():171-80.
2005: Anne Letsch; Ulrich Keilholz; Michael Fluck; Dirk Nagorsen; Anne Marie Asemissen; Alexander Schmittel; Eckhard Thiel; Carmen Scheibenbogen
Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patients.
International journal of cancer. Journal international du cancer 2005;114(6):936-41.
2005: Olaf Penack; Chiara Gentilini; Lars Fischer; Anne Marie Asemissen; Carmen Scheibenbogen; Eckhard Thiel; Lutz Uharek
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.
Leukemia 2005;19(5):835-40.
2005: Anne Marie Asemissen; Carmen Scheibenbogen; Anne Letsch; Kristoffer Hellstrand; Fredrik B Thorén; Kurt Gehlsen; Alexander Schmittel; Eckhard Thiel; Ulrich Keilholz
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):290-7.
2004: Anne Letsch; Ulrich Keilholz; Dirk Schadendorf; Geraldine Assfalg; Anne Marie Asemissen; Eckhard Thiel; Carmen Scheibenbogen
Functional CCR9 expression is associated with small intestinal metastasis.
The Journal of investigative dermatology 2004;122(3):685-90.
2003: Carmen Scheibenbogen; Anne Letsch; Alexander Schmittel; Anne Marie Asemissen; Eckhard Thiel; Ulrich Keilholz
Rational peptide-based tumour vaccine development and T cell monitoring.
Seminars in cancer biology 2003;13(6):423-9.
2002: Carmen Scheibenbogen; Yuansheng Sun; Ulrich Keilholz; Mingxia Song; Stefan Stevanovic; Anne Marie Asemissen; Dirk Nagorsen; Eckhard Thiel; Hans-Georg Rammensee; Dirk Schadendorf
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.
International journal of cancer. Journal international du cancer 2002;98(3):409-14.
2002: Danila Valmori; Carmen Scheibenbogen; Valérie Dutoit; Dirk Nagorsen; Anne Marie Asemissen; Verena Rubio-Godoy; Donata Rimoldi; Philippe Guillaume; Pedro Romero; Dirk Schadendorf; Martin Lipp; Pierre-Yves Dietrich; Eckhard Thiel; Jean-Charles Cerottini; Danielle Liénard; Ulrich Keilholz
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer research 2002;62(6):1743-50.
2001: Anne Marie Asemissen; Dirk Nagorsen; Ulrich Keilholz; Anne Letsch; Alexander Schmittel; Eckhard Thiel; Carmen Scheibenbogen
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.
Journal of immunological methods 2001;251(1-2):101-8.
2000: Dirk Nagorsen; Ulrich Keilholz; L Rivoltini; Alexander Schmittel; Anne Letsch; Anne Marie Asemissen; G Berger; H J Buhr; Eckhard Thiel; Carmen Scheibenbogen
Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.
Cancer research 2000;60(17):4850-4.